Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medivation rockets 120% on drug study
Medivation rockets 120% on drug study
Medivation rockets 120% on drug study
Submitted by
admin
on November 3, 2011 - 12:21pm
Source:
Marketwatch
News Tags:
Medivation
prostate cancer
MDV3100
Headline:
Medivation rockets 120% on drug study
Do Not Allow Advertisers to Use My Personal information
